Use of new direct thrombin inhibitor may be as effective as current standard treatment

(San Diego, Calif., December 7, 2003) The use of ximelagatran in patients with acute venous thromboembolism is as safe and effective as the current standard treatment of enoxaparin, according to a study presented today during the 45th Annual Meeting of the American Society of Hematology (ASH). Ximelagatran is a novel oral direct thrombin inhibitor that, in its activated form, selectively inhibits free and clot-bound thrombin, a key enzyme in the body's coagulation pathway.

"We believe that ximelagatran holds promise as a new agent for the treatment of venous thromboembolism, a sometimes fatal disease that affects an estimated 250,000 to two million Americans a year," said Charles Francis, M.D., of the University of Rochester, Rochester, N.Y., presenting author of the study. "Further studies are needed to confirm its effectiveness over currently available treatments."

Researchers of this international, double-blind, double-dummy study (known as the Thrive Treatment Study) randomized 2,489 patients to either ximelagatran (36 mg twice a day) for six months (1,240 patients) or enoxaparin (1 mg/kg twice a day) for a minimum of five days followed by warfarin (target INR 2.0 to 3.0) for six months (1,249 patients). All participants, 53 percent of whom were men, had acute deep vein thrombosis and 37 percent had confirmed pulmonary embolism.

During six months of treatment, oral ximelagatran was as effective as enoxaparin/warfarin in preventing recurrent venous thromboembolism in patients with acute deep vein thrombosis, 2.1 percent versus 2.0 percent, respectively. Ximelagatran also was associated with a favorable outcome with respect to major bleeding (1.3 percent versus 2.2 percent) and mortality rates (2.3 percent versus 3.4 percent). Laboratory evaluation showed an incidence of serum alanine aminotransferase (ALAT, commonly measured to assess liver function) elevations of 9.6 percent, which is greater than three times the upper lim

Contact: Aimee Frank
American Society of Hematology

Page: 1 2 3

Related biology news :

1. New dye directly reveals activated proteins in living cells
2. Fossils reveal direct link between global warming and genetic diversity in wildlife
3. UCSB professor and director receives two national awards
4. Briggs takes to the molecular level Darwins findings on plants sensing the direction of light
5. Molecular traffic cop directs cellular signals
6. Protein controls acid in cells by direct detection of volume changes, study finds
7. New research supports theory that indirect transmission of chronic wasting disease
8. Chemical reaction in birds provides sense of direction during migratory flights
9. Crowding stem cells personal space directs their future
10. New polyelectrolyte inks create fine-scale structures through direct writing
11. St. Jude/Mayo Clinic study finds direct link between CBP gene and lymphoma

Post Your Comments:

(Date:2/1/2020)... ... 01, 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year ... disease. HCC is the 5th most common cancer and the 2nd leading cause of ... to incidence of HCC, while China has half of all patients suffering from liver ...
(Date:1/29/2020)... ... January 29, 2020 , ... VGXI, a world leading contract ... DNA vaccine against the novel coronavirus (2019-nCoV) that has recently emerged in Wuhan, ... $9 million from the Coalition for Epidemic Preparedness Innovations (CEPI) will fund the ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus ... a noted investor, tech entrepreneur, and former senior management consultant at McKinsey & ... Capital, the global alternative investment firm. , “Chris Thorne has exceptional business ...
Breaking Biology News(10 mins):
(Date:2/26/2020)... ... 25, 2020 , ... Continuing its leading research on human ... its safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) HMO. , 3-FL ... carbohydrates are indigestible and therefore function as a prebiotic by promoting early microbial ...
(Date:2/21/2020)... ... February 21, 2020 , ... Pharmaceutical manufacturers are under ... to adapt to new approaches like ‘Industry 4.0’ and continuous manufacturing, combat the ... medicine and therapies. But with an industry with the world’s tightest regulations and ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous fixation ... Unlike extension block design, the Inspan device fixates the spine to allow ...
(Date:2/3/2020)... YORK (PRWEB) , ... February 03, 2020 , ... ... Business Travel, Financial Services Firm Travel, Law Firm Travel, Technology Industry Travel and ... data findings, listed quarterly. Each Index illustrates the following statistics:, ...
Breaking Biology Technology:
Cached News: